Please assess the completion status of the following clinical trial:

Trial Title: TEA vs. PVB vs. PCA in Liver Resection Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Age \>/= 18 years and \</= 80 years~* Scheduled for elective hepatic resection surgery~Exclusion Criteria:~* Preexisting coagulopathy (INR \>1.5)~* Spinal stenosis~* Local infection in area where catheter will be inserted~* Severe cardiovascular disease (NYHA Class III/IV)~* Severe pulmonary disease (FEV1 \<50% of predicted value)~* Allergy or sensitivity to narcotics or local anesthetics~* BMI \>45~* Inability to give informed consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Thoracic Epidural (Type: ACTIVE_COMPARATOR): None
- Continuous Paravertebral Catheter (Type: ACTIVE_COMPARATOR): None
- Patient-Controlled Analgesia (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).